Do folate-receptor targeted liposomal photosensitizers enhance photodynamic therapy selectivity?

María García-Díaz, Santi Nonell, Ángeles Villanueva, Juan C. Stockert, Magdalena Cañete, Ana Casadó, Margarita Mora, M. Lluïsa Sagristá

Producció científica: Article en revista indexadaArticleAvaluat per experts

50 Cites (Scopus)


One of the current goals in photodynamic therapy research is to enhance the selective targeting of tumor cells in order to minimize the risk and the extension of unwanted side-effects caused by normal cell damage. Special attention is given to receptor mediated delivery systems, in particular, to those targeted to folate receptor. Incorporation of a model photosensitizer (ZnTPP) into a folate-targeted liposomal formulation has been shown to lead an uptake by HeLa cells (folate receptor positive cells) 2-fold higher than the non-targeted formulation. As a result, the photocytotoxicity induced by folate-targeted liposomes was improved. This selectivity was completely inhibited with an excess of folic acid present in the cell culture media. Moreover, A549 cells (folate receptor deficient cells) have not shown variations in the liposomal incorporation. Nevertheless, the differences observed were slighter than expected. Both folate-targeted and non-targeted liposomes localize in acidic lysosomes, which confirms that the non-specific adsorptive pathway is also involved. These results are consistent with the singlet oxygen kinetics measured in living cells treated with both liposomal formulations.

Idioma originalAnglès
Pàgines (de-a)1063-1071
Nombre de pàgines9
RevistaBiochimica et Biophysica Acta - Biomembranes
Estat de la publicacióPublicada - d’abr. 2011


Navegar pels temes de recerca de 'Do folate-receptor targeted liposomal photosensitizers enhance photodynamic therapy selectivity?'. Junts formen un fingerprint únic.

Com citar-ho